510(k) K130621
K130621 is an FDA 510(k) premarket notification submitted by Broadmaster Biotech Corporation for the device "BROADMASTER HEALTHCARE SYSTEM". The FDA issued a decision of Substantially Equivalent on Jul 30, 2013. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345. Broadmaster Biotech Corporation has 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 30, 2013
- Date Received
- Mar 8, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Blood Glucose, Over The Counter
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)